Most recent update: Friday, May 25, 2018 - 09:41

Bariatric News - Cookies & privacy policy

You are here

Mederi acquired by Restech

Restech acquires and Stretta and Secca with Mederi acquisition

Stretta and Secca will be marketed through Mederi RF LLC, a wholly owned subsidiary of Restech

Respiratory Technology Corporation (Restech) has announced the asset acquisition of Mederi Therapeutics the developer of Stretta and Secca technologies, two therapeutic options that address the growing conditions of reflux disease and gastric disease. Restech believes these innovative product lines complement Restech’s existing diagnostic devices with therapeutic solutions, provide additional clinical pathways, and broaden Restech’s global distribution network.

Stretta (for GERD) and Secca (for bowel incontinence) both utilise low-power radiofrequency (RF) energy to remodel the sphincter muscle at either end of the digestive tract, thereby improving function, providing significant symptom relief, and dramatic improvement in quality-of-life. Stretta and Secca will be marketed through Mederi RF LLC, a wholly owned subsidiary of Restech.

“This acquisition provides a unique opportunity to expand our reach across the clinical spectrum,” said Debra Krahel, CEO of Restech. “With the addition of Mederi’s technology and market penetration, and Restech’s established space in the reflux market, these complementary products will address gaps in the clinical continuum.”

No further details of the of the acquisition were made available, although announcements detailing the key staff who will join Restech’s management team will be made shortly.

Want more stories like this? Subscribe to Bariatric News!

Bariatric News
Keep up to date! Get the latest news in your inbox. NOTE: Bariatric News WILL NOT pass on your details to 3rd parties. However, you may receive ‘marketing emails’ sent by us on behalf of 3rd parties.